SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.20
Ask:
78.80
Spread: 3.60 (4.787%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Director/PDMR Shareholding

30 Jun 2025 12:30

RNS Number : 0073P
Accsys Technologies PLC
30 June 2025
 

Accsys Technologies PLC (the "Company")

Director/PDMR Grant of Share Awards under the Accsys Deferred Bonus Plan and under the Accsys Long Term Incentive Plan and Issue of Shares

The Company announces that following recommendation from its Remuneration Committee, on 27 June 2025 (the "Grant Date") it granted awards over 2,248,645 ordinary shares of €0.05 each in the Company ("Shares") under its Deferred Bonus Plan ("DBP") and granted nil cost options over 1,883,769 Shares under its 2025 Long Term Incentive Plan ("LTIP") to certain employees and the Company's Executive Directors, Jelena Arsic van Os and Sameet Vohra, as further set out below.

Deferred Bonus Plan

Awards under the DBP have been granted in respect of bonuses earned for the financial year ending 31 March 2025 over a total of 2,248,645 Shares (the "Bonus Shares"), including to the Executive Directors in such numbers as set out below. The awards to Executive Directors vest 80% on the Grant Date and 20% on the second anniversary of the Grant Date, subject in each case to the sale of such number of Bonus Shares as is required to cover each Director's respective tax and social security liabilities.

Director

Role

Number of Bonus Shares awarded

Number of Bonus Shares vesting on Grant Date

Number of Bonus Shares vesting on second anniversary of Grant Date

Jelena Arsic van Os

Chief Executive Officer

526,435

421,148

105,287

Sameet Vohra

Chief Financial Officer

178,853

143,082

35,771

 

Long Term Incentive Plan 2025 Awards

Awards of nil cost options under the LTIP have been granted over a total of 1,883,769 Shares to various senior employees, including to the Executive Directors in such numbers as are set out below, in accordance with the terms of the LTIP Rules.

The nil cost options are expected to vest three years after grant, subject to the terms of the LTIP Rules, including continued employment of the beneficiaries by the Company and satisfaction of financial and non-financial performance conditions. Details of the performance conditions will be included in the FY26 Annual Report. A two-year holding period applies following the end of the performance period for Executive Directors only.

 

 

 

Director

Role

Number of nil cost options over Ordinary Shares awarded

Jelena Arsic van Os

Chief Executive Officer

778,693

Sameet Vohra

Chief Financial Officer

425,432

 

Following the awards made under the DBP, Jelena Arsic van Os is now beneficially interested in 509,398 Shares and Sameet Vohra is now beneficially interested in 143,082 Shares.

New Share Issues

 

In satisfaction of the grant of awards under the DBP as announced above, the Company further announces the issue of 2,248,645 Bonus Shares to the Company's Employee Benefit Trust ("EBT"), the beneficiaries of which include employees and the Executive Directors.

Application for admission of the Bonus Shares to trading on AIM and Euronext Amsterdam has now been made, with admission expected on or around 3 July 2025. The Company does not hold any shares in treasury. Therefore, the total voting rights in the Company following the issue of the Bonus Shares will be 242,694,212. Following the issue of the Bonus Shares, this figure may be used by shareholders as the denominator for the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's securities under the FCA's Disclosure Guidance and Transparency Rules.

The Company shall make a further announcement once the sale of Shares, as is required to cover each Executive Director's respective tax and social security liabilities, has been completed in respect of the awards vesting on the Grant Date.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jelena Arsic van Os

2.

Reason for the notification

a)

Position / status

Chief Executive Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Award of Bonus Shares

Nil

526,435

2) LTIP 2025 award of nil cost options

Nil

778,693

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Sameet Vohra

2.

Reason for the notification

 

 

a)

Position / status

Chief Financial Officer

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer

a)

Name

Accsys Technologies plc

b)

LEI

213800HKRFK8PNUNV581

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.05 each

b)

Identification code

ISIN:  GB00BQQFX454

c)

Nature of the transaction

Transaction 1

Award of Bonus Shares under the Accsys Deferred Bonus Plan

Transaction 2

LTIP 2025 award of nil cost options

d)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

Award of Bonus Shares

Nil

178,853

LTIP 2025 award of nil cost options

Nil

425,432

e)

Aggregated information

Volume

Price

N/A

f)

Date of the transaction

27 June 2025

g)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFBLFXEQLFBBF
Date   Source Headline
23rd Jun 20203:58 pmRNSIssue of Shares and Directors' Interests
23rd Jun 20207:14 amRNSPreliminary Results for the year ended 31 March 20
15th Jun 20205:37 pmRNSNotifiable Interest – Teslin
29th May 20205:37 pmRNSTotal Voting Rights
19th May 20207:00 amRNSAppointment of Chairman Designate
12th May 20204:03 pmRNSNotifiable Interest - BGF
7th May 202011:08 amRNSIssuance of Shares
27th Mar 202012:03 pmRNSCOVID-19 Update
4th Mar 20209:36 amRNSNotifiable Interest - De Engh B.V.
28th Feb 202010:26 amRNSTotal Voting Rights
24th Feb 20207:00 amRNSCommercial Agreements with Cerdia Produktions GmbH
17th Feb 20202:18 pmRNSNotifiable Interest - De Engh B.V.
4th Feb 20203:46 pmRNSEmployee Share Participation Plan
27th Dec 20197:00 amRNSNotifiable Interest - De Engh B.V.
27th Dec 20197:00 amRNSNotifiable Interest - Janus Henderson Group
24th Dec 201910:11 amRNSNotifiable Interest - Pershing Securities Limited
23rd Dec 20192:00 pmRNSDirector Dealings
23rd Dec 20197:00 amRNSAdmission and Total Voting Rights
20th Dec 201910:07 amRNSSuccessful Results of General Meeting
20th Dec 20197:00 amRNSResults of Firm Placing and Placing and Open Offer
2nd Dec 201911:14 amRNSDirector Interests and LTIP Awards
28th Nov 20192:16 pmRNSPublication of a Prospectus
28th Nov 20197:01 amRNSInterim Results for six months ending 30 Sept 2019
28th Nov 20197:00 amRNSEquity Raise
18th Oct 20197:00 amRNSAppointment of Chief Executive Officer
30th Sep 20195:17 pmRNSAGM Results
30th Sep 20197:00 amRNSAGM Statement
17th Sep 20196:03 pmRNSNotifiable Interest - Majedie Asset Management
12th Aug 20193:13 pmRNSAGM Notification
2nd Aug 20197:00 amRNSNotifiable Interest - Teslin Participaties
17th Jul 201911:27 amRNSShare purchase by a PDMR
28th Jun 201912:04 pmRNSShare Purchase by PCA
25th Jun 20195:58 pmRNS20190625 - AXS - Directors Interest LTIP
25th Jun 20197:00 amRNSDirectorate Change
25th Jun 20197:00 amRNSPreliminary results for year ended 31 March 2019
30th Apr 20197:00 amRNSAppointment of joint broker
29th Mar 20199:01 amRNSTotal Voting Rights
25th Mar 20197:00 amRNSTrading Update Year Ending March 2019
4th Mar 20195:31 pmRNSShare purchase by a PCA
15th Feb 20197:00 amRNSIssuance of Shares
9th Jan 20197:00 amRNSAgreement with PCG to evaluate Tricoya® plant
21st Dec 20187:03 amRNSResignation of Director
20th Nov 20187:00 amRNSInterim Results for six months ending 30 Sept 2018
24th Sep 20187:00 amRNSAGM Correction Statement
18th Sep 20184:00 pmRNSAGM - Proxy Results
18th Sep 20187:00 amRNSAGM Statement
14th Aug 20187:00 amRNSNotifiable Interest - BGF
8th Aug 20182:15 pmRNSNotice of Annual General Meeting
2nd Aug 20187:00 amRNSCompletion of finance for Purchase of Land
30th Jul 20184:41 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.